OBJECTIVE: To study the clinical features and etiological spectrum of pancytopenia in children. METHODS: The clinical data of 174 children with pancytopenia between September 2003 and January 2010 were retrospectively reviewed. RESULTS: Pale face was the most common clinical manifestation (147 cases, 84.5%), followed by bleeding (87 cases, 50.0%) and fever (41 cases, 23.6%). Mild to moderate anemia, severe thrombocytopenia and mild leucopenia were common in complete blood count. Of the 174 children, pancytopenia was attributed to hematopoietic system diseases in 155 cases (89.1%) and non-hematopoietic system diseases (virus infections, systemic lupus erythematosus, hypersplenism and neuroblastoma) in 6 cases (3.4%). Aplastic anemia (91 cases, 52.3%) was the most common cause of pancytopenia, followed by myelodysplastic syndrome (37 cases, 21.3%), acute leukemia and other hematological tumours (11 cases, 6.3%) and hemophagocytic syndrome (6 cases, 3.4%). The cause of pancytopenia was not identified in 13 cases (7.5%). CONCLUSIONS: Anemia, bleeding and fever are the main clinical manifestations of pancytopenia in children. Pancytopenia is mostly caused by aplastic anemia in children. Myelodysplastic syndrome, hematological tumours and hemophagocytic syndrome are also the common causes.
Key words
Pancytopenia /
Etiology /
Clinical feature /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
［1］Gupta V, Tripathi S, Tilak V, Bhatia BD. A study of clinico-haematological profiles of pancytopenia in children［J］. Trop Doct, 2008, 38（4）: 241-243.
［2］Memon S, Shaikh S, Nizamani MA. Etiological spectrum of pancytopenia based on bone marrow examination in children［J］. J Coll Physicians Surg Pak, 2008, 18(3): 163-167.
［3］高原,姜林春,杨剑敏,王欢. 165例儿童全血细胞减少回顾性分析［J］. 检验医学, 2010, 25(6): 451-455.
［4］魏书珍, 张秋业. 儿科疾病的临床检验［M］. 第2版. 北京: 人民卫生出版社, 1998：210-469.
［5］张之南, 沈悌. 血液病诊断及疗效标准［M］. 第3版. 北京: 科学出版社, 2007.
［6］Shimamura A. Clinical approach to marrow failure［J］. Hematology Am Soc Hematol Educ Program, 2009: 329-337.
［7］中国小儿血液与肿瘤杂志编辑委员会.小儿再生障碍性贫血诊疗建议［J］.中国小儿血液与肿瘤杂志, 2007, 12(5): 236-240.
［8］Steensma DP. The changing classification of myelodysplastic syndromes: what′s in a name［J］. Hematology Am Soc Hematol Educ Program, 2009：645-655.
［9］Orazi A, Czader MB. Myelodysplastic syndromes［J］. Am J Clin Pathol, 2009, 132(2):290-305.
［10］van den Heuvel-Eibrink MM. Paroxysmal nocturnal hemoglobinuria in children［J］. Paediatr Drugs, 2007, 9(1): 11-16.
［11］Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome［J］. Blood, 2002, 100(12): 3897-3902.
［12］汤永民. 加强儿童噬血细胞综合征的早期诊断与干预研究［J］. 临床儿科杂志, 2009, 27(8): 705-708.
［13］邵宗鸿，付蓉. 免疫相关性血细胞减少症——一种新认知的疾病(下)［J］. 中国医刊, 2005, 40(2): 6-9.
［14］郭海霞，李文益,方建培,夏焱,薛红漫. 儿童系统性红斑狼疮血液生化的改变［J］.中国当代儿科杂志, 2001,3(2):189-190.
［15］肖娟，魏珉，宋红梅，仇佳晶. 儿童系统性红斑狼疮相关再生障碍性贫血2例报告并文献复习［J］. 临床儿科杂志, 2010, 28(6): 560-563.
［16］Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia［J］. Blood, 2006, 108（8）: 2509-2519.
PDF(998 KB)
